Nanologistics, a Lithuanian biotech startup, specializes in developing advanced liposomal drug delivery systems to improve absorption and minimize side effects, with innovative carriers ensuring safe, precise delivery of complex molecules. Supported by state funding and a partnership with Vytautas Magnus University, the company brings cutting-edge CRO services to enhance bioavailability and therapeutic outcomes, driving innovation in biotechnology with a dedicated team of experts and seeking partners to advance health and wellness solutions.
No comments available.
Leave your rating & comment